Anhui Huaheng Biotechnology Co. Ltd. A

SHG:688639 China Biotechnology
Market Cap
$1.23 Billion
CN¥9.03 Billion CNY
Market Cap Rank
#8443 Global
#1605 in China
Share Price
CN¥36.12
Change (1 day)
+3.56%
52-Week Range
CN¥26.59 - CN¥41.34
All Time High
CN¥85.44
About

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-pantothenate calcium, D-panthenol, and inositol; bio-based new material mon… Read more

Anhui Huaheng Biotechnology Co. Ltd. A (688639) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.015x

Based on the latest financial reports, Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.01 Million) by net assets (CN¥2.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Anhui Huaheng Biotechnology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Anhui Huaheng Biotechnology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Huaheng Biotechnology Co. Ltd. A ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2024)

The table below shows the annual cash flow conversion efficiency of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.56 Billion CN¥199.79 Million 0.078x -53.14%
2023-12-31 CN¥1.83 Billion CN¥304.28 Million 0.167x -30.91%
2022-12-31 CN¥1.48 Billion CN¥357.43 Million 0.241x +198.23%
2021-12-31 CN¥1.18 Billion CN¥95.70 Million 0.081x -63.84%
2020-12-31 CN¥489.78 Million CN¥109.57 Million 0.224x -54.55%
2019-12-31 CN¥368.68 Million CN¥181.48 Million 0.492x +71.02%
2018-12-31 CN¥310.29 Million CN¥89.31 Million 0.288x -42.61%
2017-12-31 CN¥210.73 Million CN¥105.69 Million 0.502x +60.67%
2016-12-31 CN¥176.26 Million CN¥55.02 Million 0.312x +1.31%
2015-12-31 CN¥114.46 Million CN¥35.27 Million 0.308x -45.45%
2014-12-31 CN¥54.10 Million CN¥30.56 Million 0.565x -71.96%
2013-12-31 CN¥20.46 Million CN¥41.21 Million 2.014x +332.61%
2012-12-31 CN¥7.80 Million CN¥-6.76 Million -0.866x --